HT
NBRV

HAP Trading’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

HAP Trading’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-908
Closed -$2K – 3015
2021
Q4 		$2K Buy
908
+172
+23% +$4.07K ﹤0.01% 2423
2021
Q3 		$1K Buy
736
+116
+19% +$3.27K ﹤0.01% 2383
2021
Q2 		$4K Buy
+620
New +$23.1K ﹤0.01% 2208
2021
Q1 		– Sell
-468
Closed -$5K – 2778
2020
Q4 		$5K Buy
+468
New +$50.7K ﹤0.01% 2042
2020
Q3 		– Sell
-67
Closed -$2K – 2049
2020
Q2 		$2K Buy
+67
New +$11.2K ﹤0.01% 1635
2019
Q4 		– Sell
-119
Closed -$2K – 1585
2019
Q3 		$2K Buy
+119
New +$67.1K ﹤0.01% 1191

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $219M AUM 33.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return